3Wolf G, Chen S, Ziyadeh FN. From the periphery of the glornerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes, 2005,54 (6) : 1626 - 1634.
4Van Den Berg JG,van den Bergh Weerma MA,Assmann KJ ,et al. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomenflopathies. Kidney Int,2004,66(5):1901 - 1906.
5Gruden G,Perin PC,Camussi G. Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology. Curr Diabetes Rev,2005,1 (1) :27 - 40.
6Benigni A, Gagliardini E, Tomasoni S, et al. Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy. Kidney Int,2004,65(6) :2193 -2200.
7Siu B,Saha J ,Smoyer WE, et al. Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment. BMC Nephrol,2006,7:6.
8Wang G,Lai FM, Lai KB, et al. Messenger RNA expression of podoe - yte - associated molecules in the urinary sediment of patients with diabetic nephropathy. Nephron Clin Pratt,2007,106 (4) :c169 - c179.
